Pictet Asset Management Holding SA trimmed its position in Humana Inc. (NYSE:HUM – Free Report) by 12.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 67,283 shares of the insurance provider’s stock after selling 9,447 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Humana were worth $11,666,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the company. Montag A & Associates Inc. increased its position in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC raised its stake in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new stake in Humana during the 4th quarter worth about $27,000. Reflection Asset Management bought a new position in Humana in the 4th quarter worth about $29,000. Finally, Rosenberg Matthew Hamilton increased its position in shares of Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have recently commented on HUM. Wolfe Research upgraded shares of Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Mizuho raised their price target on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Wells Fargo & Company cut shares of Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. Morgan Stanley lifted their price objective on Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a research note on Thursday, June 4th. Finally, Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $293.09.
Humana Trading Down 3.2%
Shares of HUM opened at $396.38 on Friday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $415.00. The firm has a market cap of $47.59 billion, a price-to-earnings ratio of 42.39, a PEG ratio of 2.33 and a beta of 0.71. The firm has a 50 day moving average price of $318.28 and a 200-day moving average price of $249.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter last year, the firm earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities research analysts forecast that Humana Inc. will post 9.03 earnings per share for the current year.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
